APA (7th ed.) Citation

C, S., I, S., V, A., EA, O., AM, M., A, R., . . . MA, M. (2026). Pharmaceutical Co-Crystal Formulation of Rivaroxaban with Niacinamide: Preparation, Characterization, and In Vitro Release Evaluation. Materials (Basel, Switzerland), 19(7), . https://doi.org/10.3390/ma19071336

Chicago Style (17th ed.) Citation

C, Solomon, et al. "Pharmaceutical Co-Crystal Formulation of Rivaroxaban with Niacinamide: Preparation, Characterization, and In Vitro Release Evaluation." Materials (Basel, Switzerland) 19, no. 7 (2026). https://doi.org/10.3390/ma19071336.

MLA (9th ed.) Citation

C, Solomon, et al. "Pharmaceutical Co-Crystal Formulation of Rivaroxaban with Niacinamide: Preparation, Characterization, and In Vitro Release Evaluation." Materials (Basel, Switzerland), vol. 19, no. 7, 2026, https://doi.org/10.3390/ma19071336.